Over 70 hemophilia patients undergoing treatment in Qatar

4/30/2016 9:52:39 PM

(MENAFN- The Peninsula) DOHA: More than 70 patients with rare bleeding disorders including children and adults receive medication (clotting factor) from pharmacies at Hamad General hospital (HGH) and the National Center for Cancer Care and Research (NCCCR) according to a senior official.

Hemophilia (bleeding disorder) occurs because of defects in the body’s blood vessels or the coagulation mechanism which is responsible for coagulating (clotting) blood from a liquid into a solid after surgery or injury.

The incidence of hemophilia is quite low although statistics on its incidence vary.

“When a person without hemophilia bleeds normal levels of clotting factor a protein in the blood causes the blood to clot and stops the bleeding.

“However hemophiliacs (people with hemophilia) have lower levels of clotting factor in the blood and bleeding continues for much longer periods” said Dr Ahmed Abdulaziz Abdelbari Clinical Pharmacist at HGH.

“An affected individual can bleed profusely for a longer time after trauma. These haemorrhages commonly occur in joints especially knees ankles and elbows and into tissues and muscles” Dr Abdelbari told a symposium held to mark World Hemophilia Day.

Hamad Medical Corporation’s (HMC) Pediatrics Hematology/Oncology Unit in collaboration with the Friends of Hemophilia Society recently hosted the two-day symposium to raise awareness of hemophilia and educate patients and their families about the condition.

More than 100 participants attended the symposium including hematologists nurses pharmacists orthopaedic surgeons and physiotherapists as well as patients their families and caregivers.

The symposium featured a number of interesting lectures and specialized workshops for healthcare professionals along with fun activities for patients and their families.

Dr Abdelbari said “We are excited to have successfully organised this important symposium for the seventh time. It was an excellent opportunity for us to raise awareness of hemophilia and advocate for people affected by different kinds of bleeding disorders in Qatar.

“The event builds on HMC’s commitment to providing the safest most effective and most compassionate care to each and every one of our patients.

“We encourage individuals across different disciplines to promote discussions and think of ways that will improve the quality of life of those living with this condition.”

Speakers included Dr Manuel Caraco from Hospital for Sick Children (SickKids) Canada; Dr Nicholas Goddard from Royal Free hospital UK; Dr Grieg Blamey from Maintoba Canada; and Vanessa Bouskill from SickKids Canada.

The Peninsula

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.